Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
85.22
Dollar change
-1.30
Percentage change
-1.50
%
IndexRUT P/E34.57 EPS (ttm)2.46 Insider Own0.98% Shs Outstand50.45M Perf Week0.67%
Market Cap4.33B Forward P/E19.35 EPS next Y4.40 Insider Trans0.00% Shs Float50.29M Perf Month11.63%
Income126.57M PEG2.88 EPS next Q0.89 Inst Own100.42% Short Float4.05% Perf Quarter2.89%
Sales1.27B P/S3.41 EPS this Y30.66% Inst Trans-0.61% Short Ratio4.38 Perf Half Y-5.07%
Book/sh18.57 P/B4.59 EPS next Y11.21% ROA6.21% Short Interest2.04M Perf Year0.80%
Cash/sh3.82 P/C22.31 EPS next 5Y12.00% ROE14.72% 52W Range70.74 - 95.26 Perf YTD-0.34%
Dividend Est.- P/FCF33.91 EPS past 5Y21.43% ROI7.03% 52W High-10.54% Beta0.36
Dividend TTM- Quick Ratio1.76 Sales past 5Y5.50% Gross Margin51.78% 52W Low20.47% ATR (14)1.80
Dividend Ex-Date- Current Ratio2.92 EPS Y/Y TTM32.86% Oper. Margin15.76% RSI (14)61.91 Volatility1.56% 2.20%
Employees3034 Debt/Eq0.92 Sales Y/Y TTM12.48% Profit Margin9.97% Recom1.71 Target Price105.83
Option/ShortYes / Yes LT Debt/Eq0.91 EPS Q/Q-5.58% Payout0.00% Rel Volume0.85 Prev Close86.52
Sales Surprise4.80% EPS Surprise10.46% Sales Q/Q10.14% EarningsMay 09 BMO Avg Volume464.82K Price85.22
SMA203.64% SMA509.27% SMA2000.47% Trades Volume395,113 Change-1.50%
Date Action Analyst Rating Change Price Target Change
Oct-13-22Initiated Mizuho Buy $90
Jan-27-22Downgrade Needham Buy → Hold
Dec-15-21Downgrade Citigroup Buy → Neutral $75 → $59
Aug-17-21Resumed Raymond James Outperform $75
Jun-17-21Initiated Citigroup Buy $75
May-14-21Upgrade CJS Securities Market Perform → Market Outperform
Apr-20-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21Upgrade Barrington Research Mkt Perform → Outperform $140
Jan-21-21Downgrade Barrington Research Outperform → Mkt Perform
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
Apr-04-24 06:30AM
08:00AM Loading…
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
Feb-18-24 01:26PM
10:39AM Loading…
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
09:30AM
07:10AM
06:33AM
06:10AM
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
Jan-11-24 04:05PM
01:56PM Loading…
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
07:34AM
07:00AM
06:18AM
06:00AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
09:40AM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
11:05AM
Oct-17-23 11:17AM
08:33AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
08:14AM
Oct-11-23 12:00PM
11:13AM
08:23AM
Oct-10-23 06:00AM
06:00AM
Oct-09-23 08:35AM
Oct-06-23 07:48AM
Oct-05-23 04:05PM
11:16AM
09:51AM
08:32AM
08:25AM
Oct-04-23 09:50AM
09:40AM
08:47AM
Oct-03-23 11:11AM
08:56AM
Sep-29-23 09:45AM
08:49AM
08:32AM
Sep-28-23 10:37AM
09:06AM
Sep-27-23 09:12AM
07:47AM
Sep-26-23 11:10AM
11:06AM
08:02AM
Sep-25-23 11:40AM
09:45AM
08:31AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strong Stewart WPresident, Global HospitalSep 12 '23Sale90.6522820,66816,221Sep 13 04:19 PM
Lingamneni AnilaEVP, Chief Technology OfficerSep 11 '23Sale90.002,305207,45014,495Sep 13 04:20 PM
Dockendorff Charles JDirectorSep 05 '23Sale87.6810,215895,6512,226Sep 07 04:23 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Option Exercise57.104,928281,39023,391Jul 20 04:17 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Sale90.004,928443,52018,463Jul 20 04:17 PM
Simon, ChristopherPresident & CEOJun 29 '23Option Exercise28.61196,7465,629,887414,113Jun 30 04:17 PM
Strong Stewart WPresident, Global HospitalJun 07 '23Option Exercise56.936,893392,41924,040Jun 09 04:16 PM
Strong Stewart WPresident, Global HospitalJun 07 '23Sale88.042,538223,44616,449Jun 09 04:16 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 30 '23Sale83.332,304191,99216,800Jun 01 04:19 PM